Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Prostate Cancer

Free Subscription 17.12.2018 1 AJR Am J Roentgenol 1 Am J Surg Pathol 1 BJU Int 1 BMC Urol 1 Clin Cancer Res 1 Eur Radiol 8 Eur Urol 2 Int J Cancer 2 Int J Radiat Oncol Biol Phys 4 J Cell Physiol 2 J Clin Oncol 1 J Nucl Med 1 Nat Rev Cancer 1 Nat Rev Urol 1 Oncogene 3 Oncol Rep 3 Prostate 27 Urology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. SUN C, Chatterjee A, Yousuf A, Antic T, et al
   Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
   AJR Am J Roentgenol. 2018 Dec 12:1-6. doi: 10.2214/AJR.18.20147.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg Pathol

2. BELTRAN L, Ahmad AS, Sandu H, Kudahetti S, et al
   Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry.
   Am J Surg Pathol. 2018 Dec 7. doi: 10.1097/PAS.0000000000001202.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

3. YANG YJ, Kong YY, Li GX, Wang Y, et al
   Phenotypes of Circulating Tumor Cells Predict Time to Castration Resistance in Metastatic Castration-Sensitive Prostate Cancer.
   BJU Int. 2018 Dec 7. doi: 10.1111/bju.14642.
   PubMed     Text format     Abstract available
   
   

   
   BMC Urol

4. BRUNDL J, Wallinger S, Breyer J, Weber F, et al
   Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
   BMC Urol. 2018;18:75.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

5. MOSTAGHEL EA
   Alternative Acts: Oncogenic Splicing of Steroidogenic Enzymes in Prostate Cancer.
   Clin Cancer Res. 2018 Dec 10. pii: 1078-0432.CCR-18-3410.
   PubMed     Text format     Abstract available
   
   

   
   Eur Radiol

6. OVERDUIN CG, Heidkamp J, Rothgang E, Barentsz JO, et al
   Fast 3-T MR-guided transrectal prostate biopsy using an in-room tablet device for needle guide alignment: a feasibility study.
   Eur Radiol. 2018;28:4824-4831.
   PubMed     Text format     Abstract available
   
   

   
   Eur Urol

7. BASCH EM, Scholz M, de Bono JS, Vogelzang N, et al
   Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint.
   Eur Urol. 2018 Dec 4. pii: S0302-2838(18)30932.
   PubMed     Text format     Abstract available
   
   
8. MOORE C
   Can Negative Prostate Magnetic Resonance Imaging Give Us the Reassurance We Need To Avoid Standard Biopsy? An Evidence-based Practical Approach.
   Eur Urol. 2018;74:55-56.
   PubMed     Text format    
   
   
9. HAMID S, Donaldson IA, Hu Y, Rodell R, et al
   The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
   Eur Urol. 2018 Nov 29. pii: S0302-2838(18)30592.
   PubMed     Text format     Abstract available
   
   
10. XIAO G, Yao J, Kong D, Ye C, et al
    The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7.
    Eur Urol. 2018 Dec 7. pii: S0302-2838(18)30869.
    PubMed     Text format     Abstract available
    
    
11. NYBERG T, Govindasami K, Leslie G, Dadaev T, et al
    Homeobox B13 G84E Mutation and Prostate Cancer Risk.
    Eur Urol. 2018 Dec 7. pii: S0302-2838(18)30872.
    PubMed     Text format     Abstract available
    
    
12. BURNS JA, Weiner AB, Catalona WJ, Li EV, et al
    Inflammatory Bowel Disease and the Risk of Prostate Cancer.
    Eur Urol. 2018 Dec 4. pii: S0302-2838(18)30938.
    PubMed     Text format     Abstract available
    
    
13. WEGELIN O, Exterkate L, van der Leest M, Kummer JA, et al
    The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
    Eur Urol. 2018 Dec 3. pii: S0302-2838(18)30939.
    PubMed     Text format     Abstract available
    
    
14. RUD E, Lauritzen P, Baco E
    Re: Henrik Gronberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.06.022.
    Eur Urol. 2018 Dec 4. pii: S0302-2838(18)30951.
    PubMed     Text format    
    
    

    
    Int J Cancer

15. MO RJ, Han ZD, Liang YK, Ye JH, et al
    Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8(+) tumor-associated lymphocytes and poor prognosis in prostate cancer.
    Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32061.
    PubMed     Text format     Abstract available
    
    
16. PARRY MG, Sujenthiran A, Cowling TE, Nossiter J, et al
    Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England.
    Int J Cancer. 2018 Dec 14. doi: 10.1002/ijc.32068.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

17. BRYANT AK, McKay RR, Kader AK, Parsons JK, et al
    Sub-castrate testosterone nadir and clinical outcomes in intermediate or high-risk localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 10. pii: S0360-3016(18)34080.
    PubMed     Text format     Abstract available
    
    
18. DEARNALEY D, Griffin CL, Lewis R, Mayles P, et al
    Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).
    Int J Radiat Oncol Biol Phys. 2018 Dec 6. pii: S0360-3016(18)33854.
    PubMed     Text format     Abstract available
    
    

    
    J Cell Physiol

19. ZHU WB, Zhao ZF, Zhou X
    AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1alpha/CXCR4 signaling pathway in prostate cancer.
    J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27831.
    PubMed     Text format     Abstract available
    
    
20. MADRIGAL-MARTINEZ A, Fernandez-Martinez AB, Lucio Cazana FJ
    Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways.
    J Cell Physiol. 2018;233:3590-3602.
    PubMed     Text format     Abstract available
    
    
21. AGHDAM SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, et al
    The role of microRNAs in prostate cancer migration, invasion, and metastasis.
    J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27948.
    PubMed     Text format     Abstract available
    
    
22. WANG F, Mao A, Tang J, Zhang Q, et al
    microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    J Cell Physiol. 2018 Dec 10. doi: 10.1002/jcp.27989.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

23. PARIKH RB, Prasad V
    Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?
    J Clin Oncol. 2018 Dec 11:JCO1801092. doi: 10.1200/JCO.18.01092.
    PubMed     Text format    
    
    
24. DIGNAM JJ, Hamstra DA, Lepor H, Grignon D, et al
    Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.
    J Clin Oncol. 2018 Dec 7:JCO1800154. doi: 10.1200/JCO.18.00154.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

25. HOPE TA, Goodman JZ, Allen IE, Calais J, et al
    Meta-analysis of (68)Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology.
    J Nucl Med. 2018 Dec 7. pii: jnumed.118.219501. doi: 10.2967/jnumed.118.219501.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Cancer

26. FARASHI S, Kryza T, Clements J, Batra J, et al
    Post-GWAS in prostate cancer: from genetic association to biological contribution.
    Nat Rev Cancer. 2018 Dec 11. pii: 10.1038/s41568-018-0087.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Urol

27. MAURER T, Eiber M
    Practice changing for prostate cancer: a vision of the future.
    Nat Rev Urol. 2018 Dec 13. pii: 10.1038/s41585-018-0134.
    PubMed     Text format    
    
    

    
    Oncogene

28. YANG Z, Qu CB, Zhang Y, Zhang WF, et al
    Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0602.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

29. LIAO W, Liu J, Liu B, Huang X, et al
    JIB04 induces cell apoptosis via activation of the p53/Bcl2/caspase pathway in MHCC97H and HepG2 cells.
    Oncol Rep. 2018;40:3812-3820.
    PubMed     Text format     Abstract available
    
    
30. ULLAH K, Addai Peprah F, Yu F, Shi H, et al
    The application of prostate specific membrane antigen in CARTcell therapy for treatment of prostate carcinoma (Review).
    Oncol Rep. 2018 Oct 1. doi: 10.3892/or.2018.6758.
    PubMed     Text format     Abstract available
    
    
31. GAN BL, Zhang LJ, Gao L, Ma FC, et al
    Downregulation of miR2245p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in silico analyses.
    Oncol Rep. 2018 Oct 3. doi: 10.3892/or.2018.6766.
    PubMed     Text format     Abstract available
    
    

    
    Prostate

32. ADAMO H, Hammarsten P, Hagglof C, Dahl Scherdin T, et al
    Prostate cancer induces C/EBPbeta expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
    Prostate. 2018 Dec 11. doi: 10.1002/pros.23749.
    PubMed     Text format     Abstract available
    
    
33. BARBAUD M, Frindel M, Ferrer L, Le Thiec M, et al
    68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
    Prostate. 2018 Dec 14. doi: 10.1002/pros.23751.
    PubMed     Text format     Abstract available
    
    
34. ZEDAN AH, Hansen TF, Assenholt J, Madsen JS, et al
    Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy.
    Prostate. 2018 Dec 9. doi: 10.1002/pros.23748.
    PubMed     Text format     Abstract available
    
    

    
    Urology

35. CHUNG PH, Esposito P, Wessells H, Voelzke BB, et al
    Incidence of Stress Urinary Incontinence Following Posterior Urethroplasty for Radiation-Induced Urethral Strictures.
    Urology. 2017 Nov 27. pii: S0090-4295(17)31222.
    PubMed     Text format     Abstract available
    
    
36. KARSH LI, Gross ET, Pieczonka CM, Aliotta PJ, et al
    Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Urology. 2018;115:39-44.
    PubMed     Text format     Abstract available
    
    
37. SATAKE Y, Kaiho Y, Saito H, Yamada T, et al
    Estimated Minimal Residual Membranous Urethral Length on Preoperative Magnetic Resonance Imaging Can Be a New Predictor for Continence After Radical Prostatectomy.
    Urology. 2018;112:138-144.
    PubMed     Text format     Abstract available
    
    
38. KAYE DR, Syrjamaki J, Ellimoottil C, Schervish EW, et al
    Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy.
    Urology. 2018;112:74-79.
    PubMed     Text format     Abstract available
    
    
39. CARPENTER CP, Gleason JM
    When Chemotherapy Is Not Enough-Management of Prostatic Embryonal Rhabdomyosarcoma in an Infant.
    Urology. 2018;113:200-202.
    PubMed     Text format     Abstract available
    
    
40. VETTERLEIN MW, Dalela D, Sammon JD, Karabon P, et al
    State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
    Urology. 2018;112:56-65.
    PubMed     Text format     Abstract available
    
    
41. BRASSETTI A, Lombardo R, Emiliozzi P, Cardi A, et al
    Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket.
    Urology. 2018;111:129-135.
    PubMed     Text format     Abstract available
    
    
42. RADADIA KD, Farber NJ, Shinder B, Polotti CF, et al
    Management of Postradical Prostatectomy Urinary Incontinence: A Review.
    Urology. 2018;113:13-19.
    PubMed     Text format     Abstract available
    
    
43. KO KJ, Lee CU, Kim TH, Suh YS, et al
    Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
    Urology. 2018;113:215-219.
    PubMed     Text format     Abstract available
    
    
44. ELKHOURY FF, Simopoulos DN, Marks LS
    Targeted Prostate Biopsy in the Era of Active Surveillance.
    Urology. 2018;112:12-19.
    PubMed     Text format     Abstract available
    
    
45. CHRISTIDIS D, McGrath S, Leaney B, O'Sullivan R, et al
    Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
    Urology. 2018;111:136-138.
    PubMed     Text format     Abstract available
    
    
46. HUEN KH, Bergman J
    Editorial Comment.
    Urology. 2018;118:133.
    PubMed     Text format    
    
    
47. DELAY KJ, Haney NM, Chiang J, Stewart C, et al
    Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective Analysis.
    Urology. 2018;113:160-165.
    PubMed     Text format     Abstract available
    
    
48. RASKOLNIKOV D, Gore JL
    Editorial Comment.
    Urology. 2018;116:74-75.
    PubMed     Text format    
    
    
49. CURCI NE, Lane BR, Shankar PR, Noyes SL, et al
    Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
    Urology. 2018;116:137-143.
    PubMed     Text format     Abstract available
    
    
50. SHAH N, Ioffe V
    Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65).
    Urology. 2018;116:232.
    PubMed     Text format    
    
    
51. WELK B, Winick-Ng J, McClure JA, Lorenzo AJ, et al
    The Impact of the Choosing Wisely Campaign in Urology.
    Urology. 2018;116:81-86.
    PubMed     Text format     Abstract available
    
    
52. PORPIGLIA F, Fiori C, Checcucci E, Amparore D, et al
    Augmented Reality Robot-assisted Radical Prostatectomy: Preliminary Experience.
    Urology. 2018;115:184.
    PubMed     Text format     Abstract available
    
    
53. HENRY MA, Howard DH, Davies BJ, Filson CP, et al
    Physician Reimbursement for Prostate Biopsies Falls as Procedures Shift From Offices to Facilities.
    Urology. 2018;115:96-101.
    PubMed     Text format     Abstract available
    
    
54. HEIDLER S, Drerup M, Lusuardi L, Bannert U, et al
    The Correlation of Prostate Volume and Prostate-specific Antigen Levels With Positive Bacterial Prostate Tissue Cultures.
    Urology. 2018;115:151-156.
    PubMed     Text format     Abstract available
    
    
55. FULLER TW, Ristau BT, Tepe SM, Benoit RM, et al
    Characterizing Clinically Meaningful Changes in Lower Urinary Tract Symptoms Using the American Urological Association Symptom Index.
    Urology. 2018;115:139-143.
    PubMed     Text format     Abstract available
    
    
56. MEYER AR, Joice GA, Schwen ZR, Partin AW, et al
    Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.
    Urology. 2018;115:8-13.
    PubMed     Text format     Abstract available
    
    
57. NEAD KT, Boldbaatar N, Yang DD, Sinha S, et al
    Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis.
    Urology. 2018;114:155-162.
    PubMed     Text format     Abstract available
    
    
58. FRIEDL A, Schneeweiss J, Sevcenco S, Eredics K, et al
    In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve.
    Urology. 2018;114:139-146.
    PubMed     Text format     Abstract available
    
    
59. SRIVASTAVA A, Joice GA, Patel HD, Manka MG, et al
    Impact of Adjuvant Radiation on Artificial Urinary Sphincter Durability in Postprostatectomy Patients.
    Urology. 2018;114:212-217.
    PubMed     Text format     Abstract available
    
    
60. SHAPIRO DD, Goodspeed DC, Bushman W
    Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures.
    Urology. 2018;114:207-211.
    PubMed     Text format     Abstract available
    
    
61. WEAVER JK, Kim EH, Vetter JM, Shetty A, et al
    Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
    Urology. 2018;113:119-128.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: